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Hereditary spastic paraplegias (HSPs), a group of neurodegenerative disorders that cause progressive spasticity of
the lower limbs, are characterized by clinical and genetic heterogeneity. To date, three loci for autosomal recessive
HSP have been mapped on chromosomes 8p, 16q, and 15q. After exclusion of linkage at these loci, we performed
a genomewide search in a consanguineous Italian family with autosomal recessive HSP complicated by mild mental
retardation and distal motor neuropathy. Using homozygosity mapping, we obtained positive LOD scores for
markers on chromosome region 3q27-q28, with a maximum multipoint LOD score of 3.9 for marker D3S1601.
Haplotype analysis allowed us to identify a homozygous region (4.5 cM), flanked by markers D3S1580 and
D3S3669, that cosegregates with the disease. These data strongly support the presence, on chromosome 3q27-28,
of a new locus for complicated recessive spastic paraplegia, which we have named “SPG14.”
Hereditary spastic paraplegias (HSPs) are a heteroge-
neous group of neurodegenerative disorders character-
ized by progressive spasticity of the lower limbs. The
common neuropathologic finding is axonal degenera-
tion, especially that which involves the terminal ends, in
the longest fibers of the corticospinal tracts (Behan and
Maia 1974). From a clinical point of view, HSPs are
classically classified either as pure forms, when the spas-
tic paraplegia is the exclusive manifestation (with oc-
casional involvement of the dorsal columns or bladder
symptoms), or as complicated forms, when spasticweak-
ness of the lower limbs occurs in association with further
neurological or nonneurological features, including
mental retardation, optic atrophy, retinopathy, extra-
pyramidal disturbance, dementia, ataxia, and dysarthria
(Harding 1981; Fink 1997). The number of HSPs that
can be considered to be pure is rapidly shrinking as we
learn more about the expanding variety of phenotypes
(Figlewicz and Bird 1999). HSP is characterized by ge-
netic heterogeneity: in addition to the more frequent au-
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tosomal dominant inheritance (ADHSP) that occurs in
the majority (70%–80%) of families, autosomal reces-
sive (ARHSP) and X-linked recessive inheritance have
been reported for both pure and complicated forms
(Harding 1981; Polo et al. 1993; Coutinho et al. 1999;
Reid 1999).
As a result of genetic linkage studies, seven loci
(known as “SPGs”) for autosomal dominant pure forms
have thus far been mapped on chromosomes 14q (SPG3
[MIM 182600]) (Hazan et al. 1993), 2p (SPG4 [MIM
182601]) (Hazan et al. 1994), 15q (SPG6 [MIM
600363]) (Fink et al. 1995), 8q (SPG8 [MIM 603563])
(Hedera et al. 1999; Reid et al. 1999b), and 12q (SPG10
[MIM 604187]) (Reid et al. 1999a), and two new loci
have recently been mapped on chromosomes 19q
(SPG12 [MIM 604805]) (Reid et al. 2000) and 2q
(SPG13) (Fontaine et al. 2000). Finally, a complicated
form with cataracts, gastroesophageal reflux, and amy-
otrophy has been mapped on chromosome 10q (SPG9
[MIM 601162]) (Seri et al. 1999). ARHSP occurs rarely,
and three forms have been identified on chromosomes
8p (SPG5 [MIM 270800]) (Hentati et al. 1994), 16q
(SPG7 [MIM 602783]) (De Michele et al. 1998), and
15q (SPG11 [MIM 604360]) (Martinez Murillo et al.
1999).
Only for SPG7 and SPG4 have the genes responsible
for the disease been characterized. Mutations in a gene
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Figure 1 Pedigree of the family with ARHSP. Blackened and unblackened symbols represent affected and unaffected individuals, respectively.
Genetic map is according to information from the Genetic Location Database. Haplotype analysis for the 3q27-q28 region showed a homozygous
region cosegregating with the disease. Boxes represent the disease-bearing chromosome; blackened portions of the boxes, the regions of ho-
mozygosity carried only by affected individuals; arrows, recombination events. Bracketed haplotypes are deduced.
that encodes for paraplegin, a protein with mitochon-
drial localization and a chaperon-like function, have
been found in both pure and complicated forms of
SPG7-linked ARHSP (Casari et al. 1998). Recently, the
gene responsible for SPG4-linked ADHSP has been iden-
tified; it encodes for a member of the AAA protein family
known as “spastin” (Hazan et al. 1999). Two X-linked
recessive forms have been described; the loci are mapped
on regions Xq28 (SPG1 [MIM 312900]) (Kenwrick et
al. 1986) and Xq22 (SPG2 [MIM 312920]) (Keppen et
al. 1987) and are caused by mutations in the L1CAM
gene and the PLP gene, respectively.
In this study, we report linkage analysis results for a
family from northeastern Italy. We have gathered infor-
mation on a few generations, but our findings have re-
vealed complicated HSP in only three members of a gen-
eration including 12 siblings (fig. 1). Considering that
the parents were closely related by blood (first cousins),
that only 3/12 parents were affected, and that all their
offspring were normal, we deduced that this was a form
of ARHSP. All living affected (one male and two females)
and nonaffected (three males and five females) family
members were neurologically examined (by G.F.M. and
V.S.). The age at onset was, on average, 30 years, and
the three affected individuals were clinically examined
at the age of 62, 54, and 52 years, respectively. The
clinical picture was similar for all individuals who
showed abnormal gait as a presenting symptom. In all
cases, clinical features were characterized by spastic gait,
hyperreflexia, and mild lower-limb hypertonicity. Bilat-
eral pes cavus was present in all cases, and plantar re-
sponses were extensor. The results of electromyelo-
graphic studies showed a distal motor neuropathy; in
particular, motor nerve conduction velocity (MCV) was
significant in the superficial peroneal nerve, with a ho-
mogeneous delay occurring among the three affected in-
dividuals, for whom the MCV was 37–38 m/s. Results
of a sural-nerve biopsy performed in the index patient
were normal. All affected members showed neuropsy-
chological impairment; this was characterized, in par-
ticular, by mild mental retardation, visual agnosia, and
short- and long-term memory deficiency, in addition to
signs of perseveration and confabulation. None of the
affected individuals displayed abnormalities on electro-
encephalography. Results of computed tomography and
magnetic-resonance imaging of the brain were normal
in the index patient (individual II:8). All patients were
able to walk unaided.
For molecular analysis, the blood samples of 11 family
members (4 males and 7 females) from the fourth gen-
eration were collected; for each of them, informed con-
sent was obtained and current privacy legislation was
followed. The family’s genomic DNA was extracted
from whole blood samples (10 ml) by use of a salting-
out procedure (Miller et al. 1988; modified).
To exclude the known ARHSP loci, we used published
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Table 1
Two-Point LOD Scores for Selected Markers in the 3q27-q28
Region
MARKER
LOD SCORE AT v p
Zmax vmax.00 .01 .05 .10 .20 .30 .40
D3S1262  1.20 .01 .34 .42 .26 .06 .42 .2
D3S3651  1.20 .02 .30 .37 .20 .04 .37 .2
D3S1580  .75 1.23 1.25 .99 .59 .20 1.25 .1
D3S3530 2.70 2.64 2.40 2.10 1.49 .89 .34 2.70 0
D3S1294 2.71 2.65 2.41 2.11 1.50 .90 .34 2.71 0
D3S2747 2.71 2.65 2.41 2.11 1.50 .90 .34 2.71 0
D3S1601 2.70 2.65 2.42 2.14 1.55 .95 .37 2.70 0
D3S3663 1.28 1.26 1.16 1.02 .75 .46 .18 1.28 0
D3S3669  .96 1.44 1.47 1.19 .77 .32 1.47 .1
D3S2305 .99 .97 .89 .79 .57 .35 .14 .99 0
D3S1305  1.03 .39 .17 .01 .03 .02 .03 .3
D3S1265 .99 .97 .89 .79 .57 .35 .14 .99 0
markers D8S260 and D8S285, for SPG5; D16S520,
D16S303, and D16S3023, for SPG7; and D15S1007 and
D15S1012, for SPG11 (The Genome Database). To map
the disease gene, we performed a genomewide search
using the ABI PRISM Linkage Mapping Set, version 2
(LMS2 [PE Biosystems]). The PCR reactions were per-
formed according to the conditions described in the
LMS2 user’s manual. PCR products for each set ofmark-
ers were loaded in a 7% denaturing polyacrylamide gel
(BioRad), were separated by electrophoresis on an
ABI373 automatic sequencer, and were analyzed using
GENESCAN 672 1.1 and GENOTYPER 1.0 software
(ABI).
Potential LOD scores were calculated by the SLINK
program (Weeks et al. 1990). Two-point linkage analysis
was performed by the MLINK program from the LINK-
AGE package, version 5.2 (Lathrop et al. 1984), under
the assumption of equal allele frequencies and equal
male and female recombination rates. Multipoint link-
age analysis was performed using GENEHUNTER, ver-
sion 1.3, software (Kruglyak et al. 1996), which allowed
us to avoid the computing constraints derived from the
presence of the consanguinity loop in this family. The
genetic intermarker distances used in the analysis were
the sex-averaged distances based on publishedmaps (Ge-
netic Location Database). The disease was assumed to
have an autosomal recessive inheritance, with complete
penetrance and an allele frequency of .410
By means of linkage analysis to known ARHSP loci
mapping on chromosomes 8p, 16q, and 15q, we ob-
tained negative LOD scores, with values !2 for all
markers analyzed, at recombination fraction (v) 0 (data
not shown). These results suggest the involvement of a
different gene for ARHSP in this family.
After exclusion of the known loci, we performed a ge-
nomewide search using a total of 382/400 fluorescent
labeled markers from the LMS2 (Weissenbach et al. 1992;
Gyapay et al. 1994; Dib et al. 1996), since the X chro-
mosome was excluded. A LOD score of 11 was obtained
for fourmarkers: D1S2726, on chromosome 1 (Zp 1.43,
at v p 0.00); D3S1580 and D3S1601, on chromosome
3 (Z p 1.23, at v p 0.05, and Z p 2.71, at v p 0.00,
respectively); and D9S1677, on chromosome 9 (Z p
1.19, at vp 0.00). With a positive LOD score confirmed,
in all affected individuals, by the homozygous status of
alleles for the marker D3S1601, and given the proximity
to marker D3S1580 (∼4 cM), the following microsatellite
markers were analyzed on the 3q27-q28 region:
D3S3530, D3S1294, D3S1288, and D3S2747 (mapping
between LMS2 markers D3S1580 and D3S1601), and
D3S3651, D3S3320, D3S2363, D3S3663, D3S3557,
D3S2418, D3S3669, D3S2305, D3S1523, D3S2748,
D3S240, D3S1305, and D3S1265 (flanking this interval).
Annealing temperatures in the PCR reactions were opti-
mized for each of these markers; PCR products were sep-
arated in a 9% denaturing polyacrylamide gel and were
analyzed by silver staining (Santos et al. 1993). Themark-
ers D3S1288, D3S3320, D3S2363, D3S1523, D3S2748,
and D3S240 were uninformative, and, for this reason,
they have been excluded from linkage and haplotype anal-
yses. As shown in table 1, the maximum two-point LOD
score ( ) for the markers D3S1294 and D3S2747 wasZmax
2.71, at v p 0. This value was very close to the Zmax
obtained by analysis of 100 simulated pedigrees by use
of SLINK software (simulated ). MultipointZ p 2.8max
linkage analysis performed using the informative markers
(D3S1262, D3S3651, D3S1580, D3S3530, D3S1294,
D3S2747, D3S1601, D3S3663, D3S3669, D3S2305, and
D3S1305) gave at marker D3S1601, with aZ p 3.9max
peak greater than the threshold of 3 between markers
D3S1580 and D3S3669.
Haplotype reconstruction showed a homozygous re-
gion on chromosome 3 cosegregating with the disease
in affected individuals. Considering the recombination
events with loss of homozygosity in the affected indi-
viduals, an interval of ∼16 cM defined, at the centro-
meric and telomeric boundary, by markers D3S3651 and
D3S1305 (recombination events in individuals II:6 and
II:8, respectively), was individuated (fig. 1). If we also
consider the nonaffected individuals, because of the ho-
mozygous status for the marker D3S1580 and because
of the recombination event between markers D3S1580
and D3S3530 in individual II:1, the upper limit can be
defined by the marker D3S1580. The definition of the
lower limit was based on the haplotype of individual II:
9; recombination between markers D3S3663 and
D3S3669 brought a homozygous region in this nonaf-
fected individual. These two events restricted the can-
didate region to an interval of 4.5 cM cosegregating in
homozygosis in all affected subjects and flanked by
markers D3S1580 and D3S3669. In individual II:9, the
same lower recombination could occur betweenmarkers
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D3S1601 and D3S3663, but this could not be clearly
determined as a result of a homozygous allele status in
one of the parents. To accept this possibility, and, if so,
to further restrict the region by ∼0.4 cM, we analyzed
two close markers (D3S3557 and D3S2418), which un-
fortunately gave the same result as did D3S3663 (data
not shown). These results demonstrate the existence of
a new locus for the complicated ARHSP, which we have
denoted as “SPG14,” on chromosome 3q27-q28.
In recent years, a series of studies have revealed the
extreme clinical and genetic heterogeneity associated
with HSP. This has led to the discovery of important
information on the clinical aspects of the disorder, in the
search for a possible genotype-phenotype correlation.
With regard to the autosomal dominant pure HSPs, sev-
eral studies of wide samples of families support a sig-
nificant locus-phenotype correlation as far as the age at
onset is concerned (Reid 1999; Reid et al. 1999c). As
for the recessive forms, to date, only three loci have been
mapped (on chromosomes 8q [SPG5], 16q [SPG7], and
15q [SPG11], respectively). The SPG5 locus was iden-
tified in four nonconsanguineous Tunisian families with
a homogeneous clinical picture characterized by pure
HSP with a early age at onset (Hentati et al. 1994); the
SPG11 locus was identified in several small families with
either pure or complicated forms (Martinez Murillo et
al. 1999). For the SPG7 locus, the gene (for paraplegin)
has been identified, and different mutations have been
associated with the different forms of HSP (Casari et al.
1998). The ARHSPs occur less frequently than the au-
tosomal dominant forms, and the data reported in the
literature are still scarce; nevertheless, some indications
are emerging. In a sample of 46 families with this he-
reditary disorder, Coutinho (1999) has deduced that (a)
the pure form occurs with a frequency that is 58%
greater than that of the complicated or complex forms;
(b) on the basis of clinical studies, five phenotypes have
been defined (families with pure early onset and those
with pure late onset, complex families with mental re-
tardation, complex families with mental retardation and
peripheral neuropathy, and complex families with cer-
ebellar ataxia); and (c) the association between these
forms and the loci mapped to date suggests the involve-
ment of further loci, because only a minority of the fam-
ilies examined show linkage with SPG5 and SPG7.
The family in the present study is characterized by
autosomal recessive transmission and a homogeneous
phenotype in the three affected members. Other clinical
findings, such as mild mental retardation and evidence
of mild distal motor neuropathy, place this HSP among
the complicated forms. The age at onset of the disorder
is ∼30 years: this peculiar finding, associated with slow
progression of the disease, differentiates this new com-
plicated form from those that have previously been de-
scribed, for which the onset is always before adulthood
(Polo et al. 1991; Coutinho et al. 1999). On the other
hand, the phenotype in this family is similar to that
described for two families who show linkage at the
SPG11 locus and who are characterized by spastic par-
aplegia, mild mental retardation, agenesis of the corpus
callosum, and a late age at onset (Martinez Murillo et
al. 1999). However, the results of analysis of themarkers
in the 15q13-q15 region led us to exclude linkage at the
SPG11 locus and allowed us to consider the ARHSP in
this family to be a new form of HSP. Indeed, our data,
which are strongly supported by the results of multipoint
linkage analysis ( , for the marker D3S1601)Z p 3.9max
and by analysis of recombination events, made it pos-
sible to finely map a new ARHSP locus in a 4.5-cM re-
gion on chromosome 3q27-q28.
Analysis of the identified genes and partial transcripts
is essential in the search for the genes involved and for
understanding of the molecular pathology in the HSPs.
In this region, 24 Unigene EST clusters and 4 genes—
LPP (LIM domain containing preferred translocation
partner in lipoma), TP63 (tumor protein 63), SEMP1
(senescence-associated epithelial membrane protein 1),
and FGF12 (fibroblast growth factor 12)—have been
mapped to date (see the Unified Database). The FGF12
gene is a member of the fibroblast growth factor (FGF)
family, referred to as “fibroblast growth factor homol-
ogous factors” (FHFs). Each FHF is expressed in the
developing and adult nervous system, suggesting, for this
branch of the FGF family, a role in nervous system de-
velopment and function (Smallwood et al. 1996). For
these reasons, the FGF12 represents a positional can-
didate gene for SPG14.
In summary, we have identified a new locus for a
complicated form of ARHSP with distal motor neu-
ropathy and mild mental retardation. These data, in
addition to confirming the proposed genetic hetero-
geneity for the recessive forms, will be useful for im-
proving the genetic counseling of families and for ob-
taining a better definition of a clinical and molecular
classification of ARHSPs.
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